Form 4: Kingstone Executive Reports Stock Grant, Tax-Related Sale
Insider Transaction Report
Kingstone Companies' Chief Actuary, Minlei Chen, reported the acquisition of 8,624 shares through a restricted stock grant and the sale of 1,512 shares for tax withholding purposes.
Summary
- Minlei Chen, Chief Actuary and Senior VP of Kingstone Companies, Inc. (KINS), reported changes in beneficial ownership.
- Acquired 8,624 shares of common stock on March 3, 2026, through a restricted stock grant at a price of $0.
- Disposed of 1,512 shares of common stock on March 3, 2026, at $16.53 per share to cover associated withholding taxes from a vested stock grant.
- Following these transactions, beneficial ownership stands at 36,452 shares of common stock, which includes 16,060 unvested restricted shares.
- The unvested restricted shares vest in tranches: 3,333 shares on June 18, 2026; 6,520 shares on March 3, 2027; 3,333 shares on June 18, 2027; and 2,874 shares on March 3, 2028.
- Holds 10,000 stock options with an exercise price of $2.25, vesting in tranches: 3,334 shares on January 5, 2025; 3,333 shares on January 5, 2026; and 3,333 shares on January 5, 2027, with an expiration date of January 5, 2029.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this filing as slightly positive. While a portion of shares was sold for tax purposes, the underlying restricted stock grant increases the executive's equity stake, signaling continued alignment with the company's long-term performance.
Positives
- The acquisition of 8,624 shares through a restricted stock grant increases the executive's direct equity interest in Kingstone Companies, aligning management incentives with shareholder value.
- The total beneficial ownership of 36,452 shares, including unvested restricted stock and stock options, demonstrates a significant long-term stake by a key executive.
Negatives
- The disposition of 1,512 shares, although for tax withholding purposes, represents a reduction in the executive's direct common stock holdings.
Risks
- The executive's compensation structure includes a significant portion of equity-based awards, which ties a substantial part of their personal wealth to the company's stock performance, potentially influencing decision-making.
- Future stock price volatility could impact the value of the executive's unvested restricted shares and stock options.
Future Outlook
The filing details future vesting schedules for restricted stock grants and stock options, indicating a continued long-term equity incentive structure for the Chief Actuary and Senior VP through March 2028 for restricted shares and January 2029 for stock options.
Industry Context
StockSavvy.ai notes that equity compensation, including restricted stock grants and stock options, is a standard practice across the insurance and financial services industry to attract, retain, and incentivize key executives. This filing reflects a routine aspect of executive compensation packages designed to align management's interests with long-term shareholder value, consistent with practices observed in peers like Universal Insurance Holdings (UIHC) or Heritage Insurance Holdings (HRTG).
Comparison to Industry Standards
- The use of restricted stock grants and stock options for executive compensation is a common practice in the U.S. insurance sector, aligning with compensation strategies seen at companies such as Universal Insurance Holdings (UIHC) and Heritage Insurance Holdings (HRTG).
- The disposition of shares to cover tax withholding is a standard and expected event when equity awards vest, reflecting compliance with tax regulations rather than a discretionary sale.
Stakeholder Impact
- Shareholders: The increase in the executive's beneficial ownership through a restricted stock grant enhances alignment between management and shareholder interests, potentially fostering long-term value creation.
- Employees: The compensation structure for a senior executive may serve as a benchmark or signal for broader employee incentive programs within the company.
Next Steps
- Vesting of 3,334 stock options on January 5, 2025.
- Vesting of 3,333 stock options on January 5, 2026.
- Vesting of 3,333 restricted shares on June 18, 2026.
- Vesting of 3,333 stock options on January 5, 2027.
- Vesting of 6,520 restricted shares on March 3, 2027.
- Vesting of 3,333 restricted shares on June 18, 2027.
- Vesting of 2,874 restricted shares on March 3, 2028.
- Expiration of stock options on January 5, 2029.
Key Dates
| Date | Description |
|---|---|
| 01/05/2025 | 3,334 stock options vest and become exercisable. |
| 01/05/2026 | 3,333 stock options vest and become exercisable. |
| 03/03/2026 | Acquisition of 8,624 shares of common stock via restricted stock grant; Disposition of 1,512 shares of common stock for tax withholding. |
| 06/18/2026 | 3,333 unvested restricted shares vest. |
| 01/05/2027 | 3,333 stock options vest and become exercisable. |
| 03/03/2027 | 6,520 unvested restricted shares vest. |
| 06/18/2027 | 3,333 unvested restricted shares vest. |
| 03/03/2028 | 2,874 unvested restricted shares vest. |
| 01/05/2029 | Stock options expire. |
Keywords
KINS, Kingstone Companies, Form 4, Insider Transaction, Beneficial Ownership, Restricted Stock Grant, Stock Options, Executive Compensation, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.